封面
市場調查報告書
商品編碼
1629825

全球行動醫療市場 - 2024-2031

Global MHealth Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年,全球行動醫療市場規模達616.5億美元,預計2031年將達到1,622億美元,2024-2031年預測期間複合年成長率為12.9%。

mHealth(行動健康)是指行動電話和其他無線技術在醫療保健領域的應用。行動醫療的主要應用之一是透過行動裝置向消費者宣傳預防性醫療服務。除了教育之外,行動醫療在疾病監測、治療支援、流行病爆發監測和慢性病管理等各個領域中發揮著至關重要的作用。這種多樣化的應用突顯了行動技術對增強醫療服務和改善病患治療效果的重大影響。

市場動態:

驅動程式和限制

增加數位健康解決方案的使用

數位醫療解決方案的使用增加預計將推動行動醫療市場的發展。這是由於技術的不斷進步、數位醫療解決方案的增加以及即時結果的不斷提高,預計將推動行動醫療市場的成長。遠距醫療服務的成長極大地促進了行動醫療解決方案的採用,特別是在高度已開發國家和地區。據美國國立衛生研究院2024年4月稱,來自美國的數據表明,65歲以上的人中只有38%使用過mHealth應用程式來監測自己的健康狀況。

這些數位健康解決方案有助於遠端諮詢和持續的健康監測,從而提高醫療保健服務的可近性和效率。此外,包括智慧手錶和健身追蹤器在內的穿戴式技術的創新,透過實現基本健康指標的即時追蹤,正在擴展行動醫療應用的功能。例如,2023 年10 月,Cedars-Sinai 宣布正在透過一款新的行動應用程式為加州的患者擴展虛擬醫療保健,該應用程式允許個人快速輕鬆地聯繫Cedars-Sinai 專家,以提供疾病、慢性病和預防性護理。透過新的虛擬醫療保健選項 Cedars-Sinai Connect,醫療保健專業人員可以 24/7 全天候處理緊急問題,並且可以透過減少等待時間為初級保健提供當天預約。

遠距醫療和穿戴式裝置的整合正在改變行動醫療市場,使其成為現代醫療保健的重要組成部分,滿足不同人群的需求並改善整體健康結果。

隨著智慧型手機使用量的不斷成長,包括行動醫療解決方案在內的數位健康解決方案的採用預計將會增加。個人對智慧型手機的使用越來越多。例如,根據全球行動網際網路連接,預計到 2030 年,行動普及率將增至 63 億,覆蓋全球人口的 74%。

資料隱私和安全問題

應用程式設計漏洞、用戶資料保護不足、開發人員知識差距、監管合規性挑戰和用戶行為引起的資料隱私和安全問題嚴重阻礙了行動醫療市場的成長。解決這些問題對於培養消費者之間的信任和促進更廣泛地採用行動醫療解決方案至關重要。如果沒有增強的安全措施和更大的資料處理實務透明度,行動醫療技術的潛在優勢可能無法實現。因此,上述因素可能會減少行動醫療解決方案的採用,從而阻礙市場成長。

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 增加數位健康解決方案的使用
    • 限制
      • 資料隱私和安全問題
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 報銷分析
  • 專利分析
  • SWOT分析
  • DMI 意見

第 6 章:依產品類型

  • 行動醫療應用程式
    • 一般健康與健身應用程式
    • 慢性病管理應用程式
    • 女性健康應用
    • 其他醫療保健應用程式
  • 行動醫療設備
    • 血糖儀
    • 血壓計
    • 脈搏血氧儀
    • 神經監視器
    • 心臟監測儀
    • 呼吸暫停和睡眠監測器
    • 其他

第 7 章:按申請

  • 心血管疾病
  • 糖尿病
  • 胎兒監測
  • 呼吸系統疾病
  • 神經病學
  • 營養與健身
  • 其他

第 8 章:最終用戶

  • 醫療保健提供者
  • 病人/消費者
  • 其他

第 9 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章:公司簡介

  • Medtronic
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • OMRON Healthcare, Inc.
  • AliveCor, Inc.
  • AirStrip Technologies, Inc
  • AgaMatrix
  • F. Hoffmann-La Roche AG
  • Abbott
  • LifeScan IP Holdings, LLC.
  • eka.care
  • BIOTRONIK SE & Co. KG

第 12 章:附錄

簡介目錄
Product Code: HCIT8878

The global mHealth market reached US$ 61.65 billion in 2023 and is expected to reach US$ 162.20 billion by 2031, growing at a CAGR of 12.9% during the forecast period 2024-2031.

mHealth (mobile health) refers to the utilization of mobile phones and other wireless technologies in the field of healthcare. One of the primary applications of mHealth is to educate consumers about preventive healthcare services through mobile devices. Beyond education, mHealth also plays a vital role in various areas such as disease surveillance, treatment support, monitoring epidemic outbreaks, and managing chronic diseases. This diverse range of applications highlights the significant impact of mobile technology on enhancing healthcare delivery and improving patient outcomes.

Market Dynamics: Drivers & Restraints

Increasing usage of digital health solutions

Increasing usage of digital health solutions is expected to drive the mHealth market. This is due to the increasing technological advancements, increasing digital health solutions, and rising real-time results that are expected to drive the mHealth market growth. The growth of telehealth services is significantly boosting the adoption of mHealth solutions, particularly in highly advanced countries and regions. According to the National Institute of Health in April 2024, it is stated that Data from the United States suggests that only 38% of people over the age of 65 have used mHealth apps to monitor their health.

These digital health solutions facilitate remote consultations and ongoing health monitoring, thereby enhancing both accessibility and efficiency in healthcare delivery. Furthermore, innovations in wearable technology, including smartwatches and fitness trackers, are expanding the functionality of mHealth applications by enabling real-time tracking of essential health metrics. For instance, in October 2023, Cedars-Sinai announced that it is expanding virtual healthcare for patients in California through a new mobile app that allows individuals to quickly and easily access Cedars-Sinai experts for sick, chronic, and preventive care. Through the new virtual healthcare option Cedars-Sinai Connect, healthcare professionals are available 24/7 for urgent issues, and same-day appointments are accessible for primary care by reducing wait times.

This integration of telehealth and wearable devices is transforming the mHealth market, making it a vital component of modern healthcare that caters to the needs of diverse populations and improves overall health outcomes.

With the growing smartphone usage, the adoption of digital health solutions including mHealth solutions is expected to rise. There is a growing usage of smartphones among individuals. For instance, according to the Global Mobile Internet Connectivity, it is mentioned that mobile penetration is projected to increase to 6.3 billion by 2030, encompassing 74% of the global population.

Data privacy and security concerns

mHealth market's growth is significantly hindered by data privacy and security concerns arising from vulnerabilities in app design, insufficient protections for user data, developer knowledge gaps, regulatory compliance challenges, and user behavior. Addressing these issues is essential for fostering trust among consumers and promoting broader adoption of mHealth solutions. Without enhanced security measures and greater transparency regarding data handling practices, the potential advantages of mHealth technologies may go unrealized. Thus, the above factors could hinder the market growth by reducing the adoption of mHealth solutions.

Segment Analysis

The global mHealth market is segmented based on product type, application, end-user and region.

Product Type:

mHealth devices segment is expected to dominate the MHealth market share

mHealth devices segment is expected to dominate over mHealth apps. This is due to the growing adoption of wearables over the usage of mHealth apps. Individuals are often seeking convenience and effectiveness in the devices than mHealth apps. As consumers place greater emphasis on preventive healthcare, the demand for devices that support this approach is growing. mHealth devices are particularly effective in enabling users to proactively monitor their health. For instance, wearables can identify early signs of chronic conditions, allowing users to seek medical advice before problems worsen. These factors are encouraging users to adopt to mHealth devices.

Several companies are introducing advanced solutions that integrate advanced technologies and intelligence and are attracting consumers. For instance, in August 2022, GOQii introduced Smart Vital Ultra and GOQii Stream devices targeted at young adults and youth, encouraging them to lead a healthy and active lifestyle.

In November 2022, Sony launched new wearable motion trackers that let its wearer's experience metaverse up and close. Shipped in an oval-shaped charging case, the Mocopi consists of six differently colored motion trackers that have to be worn on the head, both wrists, hips, and ankles.

Geographical Analysis

North America is expected to hold a significant position in the mHealth market share

North America is expected to dominate the mHealth market due to the rising technological advancements, increasing adoption of mobile health apps and services and the presence of a large number of players in the region.

There is a widespread adoption of smartphones in the region. With the increasing number of smartphones, the number of mobile health apps installed and subscriptions are increasing.

With the growing geriatric population, the demand for mHealth solutions is rising because of their effectiveness in providing remote patient monitoring. There is a rising geriatric population in the region. For instance, the Population Reference Bureau in 2024 stated that the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 (a 47% increase), and the 65-and-older age group's share of the total population is projected to rise from 17% to 23%. The use of mHealth solutions increases with this rise.

The rising incidence of chronic diseases is also contributing to the growth of the market and is expected to increase the demand for mHealth solutions. The increasing incidence of these diseases is encouraging the market players to innovate new mHealth solutions which is contributing the market growth.

Collaborations between key companies and healthcare providers are leading to the development of advanced mobile health applications that cater to diverse health needs, from chronic disease management to fitness tracking. For instance, in June 2024, Cleveland Clinic and app developer FitNow, Inc. have launched the Cleveland Clinic Diet app, which offers health and diet advice built upon evidence-based nutrition science and clinical success, paired with a comprehensive food and fitness tracker. The app provides individualized guided support with the input of Cleveland Clinic health experts to help users make sustainable changes to their lifestyle and dietary habits for better health and well-being.

Asia-Pacific is growing at the fastest growing pace in the mHealth market

The rapid expansion of the mHealth market in the Asia-Pacific region is fueled by a combination of dynamic factors, making it a key player in the global landscape. One significant driver is the increasing prevalence of chronic diseases, which has heightened the demand for effective health management solutions.

Widespread adoption of mobile technology in healthcare, or mHealth, is now viewed as inevitable by more than half of doctors and healthcare payers in developed and emerging markets with over 60% in India. According to a new global study conducted for PwC Global Healthcare by the Economist Intelligence Unit (EIU), the pace of adoption will likely be led by emerging markets that rank highest among ten countries on a score of mHealth maturity.

Competitive Landscape

The major global players in the mHealth market include Medtronic, OMRON Healthcare, Inc., AliveCor, Inc., AirStrip Technologies, Inc, AgaMatrix, F. Hoffmann-La Roche AG, Abbott, LifeScan IP Holdings, LLC., eka.care, and BIOTRONIK SE & Co. KG among others.

  • Why Purchase the Report?
  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global MHealth market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing usage of digital health solutions
    • 4.1.2. Restraints
      • 4.1.2.1. Data privacy and security concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. mHealth Apps*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. General Health & Fitness Apps
    • 6.2.4. Chronic Disease Management Apps
    • 6.2.5. Women's Health Apps
    • 6.2.6. Other Healthcare Apps
  • 6.3. mHealth Devices
    • 6.3.1. Blood Glucose Monitors
    • 6.3.2. Blood Pressure Monitors
    • 6.3.3. Pulse Oximetry
    • 6.3.4. Neurological Monitors
    • 6.3.5. Cardiac Monitors
    • 6.3.6. Apnea and Sleep Monitors
    • 6.3.7. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Cardiovascular Diseases*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Diabetes
  • 7.4. Fetal Monitoring
  • 7.5. Respiratory Diseases
  • 7.6. Neurology
  • 7.7. Nutrition & Fitness
  • 7.8. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Healthcare Providers*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Patients/Consumers
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. The U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Medtronic*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. OMRON Healthcare, Inc.
  • 11.3. AliveCor, Inc.
  • 11.4. AirStrip Technologies, Inc
  • 11.5. AgaMatrix
  • 11.6. F. Hoffmann-La Roche AG
  • 11.7. Abbott
  • 11.8. LifeScan IP Holdings, LLC.
  • 11.9. eka.care
  • 11.10. BIOTRONIK SE & Co. KG

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us